Scarica l'app Stockscreener
10.39
1.56%
0.16
Dopo l'orario di chiusura:
10.39
Precedente Chiudi:
$10.23
Aprire:
$10.365
Volume 24 ore:
14,582
Relative Volume:
1.74
Capitalizzazione di mercato:
$60.54M
Reddito:
$503.40K
Utile/perdita netta:
$9.17M
Rapporto P/E:
5.7375
EPS:
1.8109
Flusso di cassa netto:
$-604.40K
1 W Prestazione:
-6.48%
1M Prestazione:
-14.27%
6M Prestazione:
-13.29%
1 anno Prestazione:
+26.94%
Intervallo 1D:
$10.29
$10.50
Intervallo di 1 settimana:
$10.13
$11.50
Portata 52W:
$7.10
$14.76
Daxor Corporation Stock (DXR) Company Profile
Nome
Daxor Corporation
Settore
Industria
Telefono
212-330-8500
Indirizzo
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Compare DXR vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
10.39 | 59.61M | 503.40K | 9.17M | -604.40K | 1.8109 |
ISRG
Intuitive Surgical Inc
|
469.98 | 167.61B | 10.06B | 2.88B | 2.49B | 7.876 |
BDX
Becton Dickinson Co
|
158.27 | 44.35B | 21.92B | 1.76B | 2.63B | 6.1223 |
ALC
Alcon Inc
|
75.26 | 36.19B | 10.40B | 980.00M | 1.61B | 1.9749 |
MDLN
Medline Inc
|
42.67 | 34.11B | 28.43B | 1.16B | 1.26B | 1.4457 |
RMD
Resmed Inc
|
226.31 | 33.24B | 5.40B | 1.49B | 1.78B | 10.12 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2019-05-16 | Iniziato | Ascendiant Capital Markets | Buy |
Daxor Corporation Borsa (DXR) Ultime notizie
Daxor Corporation (NASDAQ:DXR) Short Interest Update - MarketBeat
Daxor (DXR) chief medical officer Jefferies acquires shares worth $0 - Investing.com
Daxor (DXR) chief medical officer Jefferies acquires shares worth $0 By Investing.com - Investing.com Australia
Daxor (DXR) CMO boosts stake with 5,941-share equity grant - Stock Titan
Macro Review: What is the long term forecast for Daxor Corporation stockEarnings Trend Report & Daily Price Action Insights - baoquankhu1.vn
Institution Moves: What is the earnings history of Daxor CorporationChart Signals & Low Drawdown Momentum Trade Ideas - baoquankhu1.vn
Daxor Corporation to Showcase Next-Generation Portable - GlobeNewswire
Daxor to showcase next-gen portable BVA at ACC.26 session - TipRanks
Daxor (DXR) Showcases Innovative Blood Volume Analyzer at Major Cardiology Event - GuruFocus
Daxor Corporation Showcases Next-Generation Portable Blood Volume Analyzer At ACC.26 - marketscreener.com
Daxor Corporation to Showcase Next-Generation Portable Blood Volume Analyzer at ACC.26; Highlighting Clinical Outcomes and Reduced Readmissions - marketscreener.com
Blood volume test cut heart failure readmissions 56% in studies - Stock Titan
[N-CEN] DAXOR CORP SEC Filing - Stock Titan
Daxor Details Portable FDA-Cleared Blood Volume Analyzer, 'Razor-and-Blades' Kit Growth at iAccess Alpha - MarketBeat
DXR: Direct blood volume analysis drives improved outcomes and rapid revenue growth in a vast market - TradingView
Daxor (DXR) Unveils Portable Blood Volume Analyzer at Critical C - GuruFocus
Daxor Corporation Showcases New Portable Blood Volume Analyzer - marketscreener.com
Daxor to debut portable blood volume analyzer at SCCM Critical Care Congress - TipRanks
ICU blood volume test linked to 66% fewer deaths goes portable - Stock Titan
Daxor Corporation to Participate in the iAccess Virtual Alpha Best Ideas Spring Investment Conference 2026 - GlobeNewswire
Virtual investor conference to feature Daxor CEO’s 30-minute briefing - Stock Titan
Market Overview: Will Murano Global Investments Plc Equity Warrant benefit from rate cuts2026 Top Gainers & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
What analyst consensus says on Daxor Corporation stockExit Point & Fast Moving Trade Plans - Naître et grandir
Layoff Watch: Is Daxor Corporation a turnaround storyGap Up & Safe Entry Trade Reports - baoquankhu1.vn
Daxor (NYSEAMERICAN:DXR) Share Price Passes Below 200-Day Moving AverageHere's What Happened - MarketBeat
Analysts Are Bullish on These Healthcare Stocks: Niagen Bioscience (NAGE), Daxor (DXR) - The Globe and Mail
European Stocks Set for Mixed Opening Amid Geopolitical Tensions - Intellectia AI
DXR SEC FilingsDAXOR CORP 10-K, 10-Q, 8-K Forms - Stock Titan
Daxor Corporation Reports 2025 Fiscal Year Results, Operating Revenue Up 45%, Net Asset Value Rises to $9.07 per Share - marketscreener.com
Daxor Corporation CEO and President Michael Feldschuh Provides Corporate Update in Letter to Shareholders - Bitget
Daxor reports 45% revenue growth, plans regulatory shift - Investing.com
Daxor Corporation CEO and President Michael Feldschuh provides corporate update in letter to shareholders - marketscreener.com
Daxor (DXR) Records Strong Growth and Regulatory Changes in 2025 - GuruFocus
Daxor issues update in Letter to Shareholders - TipRanks
Daxor (DXR) Secures FDA Clearance for Advanced Blood Volume Anal - GuruFocus
Daxor Corporation CEO And President Michael Feldschuh Provides Corporate Update In Letter To Shareholders - TradingView
7-pound blood volume analyzer wins FDA clearance, gains hospital users - Stock Titan
Daxor Corporation Reports 2025 Fiscal Year Results: Operating Revenue Up 45%, Net Asset Value Rises to $9.07 Per Share - marketscreener.com
Daxor Corporation Reports 2025 Fiscal Year Results: - GlobeNewswire
DXR Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
FDA‑cleared BVA boosts momentum; Daxor (NASDAQ: DXR) posts NAV $9.07 and $46M operating valuation - Stock Titan
Daxor Corporation Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Short Interest in Daxor Corporation (NASDAQ:DXR) Decreases By 44.0% - MarketBeat
Daxor Corporation (DXR) Competitors - Meyka
Daxor (NASDAQ:DXR) vs. Addus HomeCare (NASDAQ:ADUS) Financial Survey - Defense World
EBIT per share of Daxor Corporation – NASDAQ:DXR - TradingView
Daxor (NYSEAMERICAN:DXR) Share Price Crosses Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Daxor continues strategic expansion, opens new BVA program in Tennessee - TipRanks
Analysts Offer Insights on Healthcare Companies: Daxor (DXR) and HealthStream (HSTM) - The Globe and Mail
Daxor (DXR) Expands BVA Program to Southern Middle Tennessee - GuruFocus
Daxor Scales Outpatient Presence; Launches BVA Diagnostic Program in Tennessee - The Manila Times
Daxor Corporation Azioni (DXR) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.95%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):